Among the companies with shares expected to actively trade in
Tuesday's session are Edwards Lifesciences Corp. (EW), Amira Nature
Foods Ltd. (ANFI) and Forest Oil Corp. (FST).
Edwards Lifesciences said the U.S. Food and Drug Administration
has approved its next-generation Edwards Sapien XT heart valve for
hard-to-treat cases of severe symptomatic aortic stenonis. The
company said the valve will be available immediately at leading
U.S. cardiovascular centers. Shares rose 5.8% to $83.00
premarket.
Amira Nature Foods, a basmati rice company based in Dubai,
posted strong sales and earnings growth in its fiscal fourth
quarter, and projected that fiscal 2015 revenue and adjusted Ebitda
would rise more than 20%. Shares jumped 29% to $16.75
premarket.
Sabine Oil & Gas LLC said its deal to acquire Forest Oil is
moving ahead, following a report that the company's $850 million
financing bridge had been pulled. "This is incorrect," said Sabine
Chief Executive David Sambrooks Tuesday morning. The all-stock
deal, agreed to in early May, is set to create a big Texas shale
player and gave beaten-down Forest Oil shares a large lift. Shares
rose 19% to $2.40 premarket.
Yingli Green Energy Holding Co.'s (YGE) first-quarter loss
narrowed as the Chinese solar-products maker recorded improving
margins. Results missed analyst expectations, but the company said
since the beginning of the second quarter its seen substantial
upside in demand from China as well as emerging markets, and
expects this trend to continue. American depositary shares rose
4.6% to $3.68 premarket.
Watchlist:
The U.S. Food and Drug Administration has granted orphan-drug
status to Alexion Pharmaceuticals Inc.'s (ALXN) Soliris for the
treatment of a rare neuromuscular disorder.
AT&T Inc. (T) will be the exclusive carrier for Amazon.com
Inc.'s (AMZN) new smartphone, which is expected to be unveiled on
Wednesday, according to The Wall Street Journal, which cited people
familiar with the plans.
Pawnshop operator Ezcorp Inc. (EZPW) said Monday it expects to
swing to a profit in the second half of the year, driven by pawn
and loan growth in the U.S. and Mexico.
FactSet Research Systems Inc. (FDS) said its fiscal
third-quarter profit dropped 3.4% as costs rose and it settled a
legal claim.
Kindred Healthcare Inc. (KND) raised its takeover bid for
Gentiva Health Services Inc. (GTIV) to about $534 million in cash,
which it plans to take directly to shareholders starting
Tuesday.
Executive recruiter Korn/Ferry International (KFY) said its
fiscal fourth-quarter earnings surged on stronger-than-expected fee
revenue.
Ocwen Financial Corp. (OCN) agreed to pay $3.7 million in a
settlement with Massachusetts to resolve allegations that the
mortgage-servicing company failed to provide required notices to
homeowners and that it unlawfully foreclosed on certain
properties.
Vertex Pharmaceuticals Inc. (VRTX) signed a letter of intent
with the Pan-Canadian Pricing Alliance concerning public
reimbursement for cystic fibrosis treatment Kalydeco. Public
reimbursement will depend on individual provinces and territories
adding Kalydeco to their drug programs, a process the company said
is ongoing.
Corporate payment technology company Wex Inc. (WEX) has agreed
to buy Evolution1, a healthcare-focused software and payment
systems business, for $533 million in cash.
Williams Cos. (WMB) plans to offer $3 billion in shares as part
of its nearly $6 billion ownership expansion in Access Midstream
Partners LP, which would give the natural-gas pipeline company a
larger presence in areas with growing energy output from shale
formations. It would be the largest follow-on stock offering in the
U.S. since Facebook's $3.9 billion equity sale in December.
Write to Maria Armental at maria.armental@wsj.com and Anna Prior
at anna.prior@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires